Table of Contents Chapter 1 Graft Versus Host Disease (GVHD) Treatment Market Overview 1.1 Graft Versus Host Disease (GVHD) Treatment Definition 1.2 Global Graft Versus Host Disease (GVHD) Treatment Market Size Status and Outlook (2015-2030) 1.3 Global Graft Versus Host Disease (GVHD) Treatment Market Size Comparison by Region (2015-2030) 1.4 Global Graft Versus Host Disease (GVHD) Treatment Market Size Comparison by Type (2015-2030) 1.5 Global Graft Versus Host Disease (GVHD) Treatment Market Size Comparison by Application (2015-2030) 1.6 Global Graft Versus Host Disease (GVHD) Treatment Market Size Comparison by Sales Channel (2015-2030) 1.7 Graft Versus Host Disease (GVHD) Treatment Market Dynamics (COVID-19 Impacts) 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/Expansion) 1.7.4 COVID-19 Impacts on Current Market 1.7.5 Post-Strategies of COVID-19 Outbreak Chapter 2 Graft Versus Host Disease (GVHD) Treatment Market Segment Analysis by Player 2.1 Global Graft Versus Host Disease (GVHD) Treatment Sales and Market Share by Player (2018-2020) 2.2 Global Graft Versus Host Disease (GVHD) Treatment Revenue and Market Share by Player (2018-2020) 2.3 Global Graft Versus Host Disease (GVHD) Treatment Average Price by Player (2018-2020) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Graft Versus Host Disease (GVHD) Treatment Market Segment Analysis by Type 3.1 Global Graft Versus Host Disease (GVHD) Treatment Market by Type 3.1.1 Monoclonal Antibodies 3.1.2 mTOR Inhibitors 3.1.3 Tyrosine Kinase Inhibitors 3.1.4 Thalidomide 3.1.5 Etanercept 3.2 Global Graft Versus Host Disease (GVHD) Treatment Sales and Market Share by Type (2015-2020) 3.3 Global Graft Versus Host Disease (GVHD) Treatment Revenue and Market Share by Type (2015-2020) 3.4 Global Graft Versus Host Disease (GVHD) Treatment Average Price by Type (2015-2020) 3.5 Leading Players of Graft Versus Host Disease (GVHD) Treatment by Type in 2020 3.6 Conclusion of Segment by Type Chapter 4 Graft Versus Host Disease (GVHD) Treatment Market Segment Analysis by Application 4.1 Global Graft Versus Host Disease (GVHD) Treatment Market by Application 4.1.1 Hospital Pharmacies 4.1.2 Retail Pharmacies 4.1.3 Online Pharmacies 4.2 Global Graft Versus Host Disease (GVHD) Treatment Revenue and Market Share by Application (2015-2020) 4.3 Leading Consumers of Graft Versus Host Disease (GVHD) Treatment by Application in 2020 4.4 Conclusion of Segment by Application Chapter 5 Graft Versus Host Disease (GVHD) Treatment Market Segment Analysis by Sales Channel 5.1 Global Graft Versus Host Disease (GVHD) Treatment Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Graft Versus Host Disease (GVHD) Treatment Revenue and Market Share by Sales Channel (2015-2020) 5.3 Leading Distributors/Dealers of Graft Versus Host Disease (GVHD) Treatment by Sales Channel in 2020 5.4 Conclusion of Segment by Sales Channel Chapter 6 Graft Versus Host Disease (GVHD) Treatment Market Segment Analysis by Region 6.1 Global Graft Versus Host Disease (GVHD) Treatment Market Size and CAGR by Region (2015-2030) 6.2 Global Graft Versus Host Disease (GVHD) Treatment Sales and Market Share by Region (2015-2020) 6.3 Global Graft Versus Host Disease (GVHD) Treatment Revenue and Market Share by Region (2015-2020) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Graft Versus Host Disease (GVHD) Treatment Market Share by Type 6.4.3 North America Graft Versus Host Disease (GVHD) Treatment Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Graft Versus Host Disease (GVHD) Treatment Market Share by Type 6.5.3 Europe Graft Versus Host Disease (GVHD) Treatment Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Graft Versus Host Disease (GVHD) Treatment Market Share by Type 6.6.3 Asia-Pacific Graft Versus Host Disease (GVHD) Treatment Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Graft Versus Host Disease (GVHD) Treatment Market Share by Type 6.7.3 South America Graft Versus Host Disease (GVHD) Treatment Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Graft Versus Host Disease (GVHD) Treatment Market Share by Type 6.8.3 Middle East & Africa Graft Versus Host Disease (GVHD) Treatment Market Share by Application 6.8.4 UAE 6.8.5 Saudi Arabia 6.8.6 South Africa 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Graft Versus Host Disease (GVHD) Treatment Players 7.1 Abbott 7.1.1 Company Snapshot 7.1.2 Product/Service Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 COVID-19 Impact on Abbott 7.2 AbbVie 7.3 Allergan 7.4 Anterogen 7.5 Astellas Pharma 7.6 Athersys 7.7 Bristol-Myers Squibb 7.8 Caladrius 7.9 Eli Lilly 7.10 GlaxoSmithKline 7.11 Glenmark 7.12 Kadmon Holdings 7.13 Merck 7.14 Mesoblast 7.15 Neovii Biotech 7.16 Novartis 7.17 Osiris Therapeutics 7.18 Pfizer 7.19 Roche 7.20 Sanofi 7.21 Soligenix 7.22 Takeda Pharmaceutical Chapter 8 Upstream and Downstream Analysis of Graft Versus Host Disease (GVHD) Treatment 8.1 Industrial Chain of Graft Versus Host Disease (GVHD) Treatment 8.2 Upstream of Graft Versus Host Disease (GVHD) Treatment 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Graft Versus Host Disease (GVHD) Treatment 8.3.1 Leading Distributors/Dealers of Graft Versus Host Disease (GVHD) Treatment 8.3.2 Leading Consumers of Graft Versus Host Disease (GVHD) Treatment Chapter 9 Development Trend of Graft Versus Host Disease (GVHD) Treatment (2021-2030) 9.1 Global Graft Versus Host Disease (GVHD) Treatment Market Size (Sales and Revenue) Forecast (2021-2030) 9.2 Global Graft Versus Host Disease (GVHD) Treatment Market Size and CAGR Forecast by Region (2021-2030) 9.3 Global Graft Versus Host Disease (GVHD) Treatment Market Size and CAGR Forecast by Type (2021-2030) 9.4 Global Graft Versus Host Disease (GVHD) Treatment Market Size and CAGR Forecast by Application (2021-2030) 9.5 Global Graft Versus Host Disease (GVHD) Treatment Market Size and CAGR Forecast by Sales Channel (2021-2030) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification

List of Tables and Figures Figure Graft Versus Host Disease (GVHD) Treatment Example Figure Global Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) Status and Outlook (2015-2030) Figure Global Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) Comparison by Region (2015-2030) Figure Global Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) Comparison by Type (2015-2030) Figure Global Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) Comparison by Application (2015-2030) Figure Global Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) Comparison by Sales Channel (2015-2030) Table Global Graft Versus Host Disease (GVHD) Treatment Sales by Player (2018-2020) Table Global Graft Versus Host Disease (GVHD) Treatment Sales Market Share by Player (2018-2020) Figure Global Graft Versus Host Disease (GVHD) Treatment Sales Market Share by Player in 2020 Table Global Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) by Player (2018-2020) Table Global Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Player (2018-2020) Figure Global Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Player in 2020 Table Global Graft Versus Host Disease (GVHD) Treatment Average Price by Player (2018-2020) Figure Global Graft Versus Host Disease (GVHD) Treatment Average Price by Player in 2020 Figure Global Graft Versus Host Disease (GVHD) Treatment Players Competition Situation – Top 5 Players’ Revenue Market Share in 2018 Figure Global Graft Versus Host Disease (GVHD) Treatment Players Competition Trends – Top 5 Players’ Revenue Market Share in 2020 Figure Example of Monoclonal Antibodies Figure Global Monoclonal Antibodies Revenue (Million $) and Growth Rate (2015-2020) Figure Example of mTOR Inhibitors Figure Global mTOR Inhibitors Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Tyrosine Kinase Inhibitors Figure Global Tyrosine Kinase Inhibitors Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Thalidomide Figure Global Thalidomide Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Etanercept Figure Global Etanercept Revenue (Million $) and Growth Rate (2015-2020) Table Global Graft Versus Host Disease (GVHD) Treatment Sales by Type (2015-2020) Table Global Graft Versus Host Disease (GVHD) Treatment Sales Market Share by Type (2015-2020) Figure Global Graft Versus Host Disease (GVHD) Treatment Sales Market Share by Type in 2020 Table Global Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) by Type (2015-2020) Table Global Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Type (2015-2020) Figure Global Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Type in 2020 Table Global Graft Versus Host Disease (GVHD) Treatment Average Price by Type (2015-2020) Figure Global Graft Versus Host Disease (GVHD) Treatment Average Price by Type in 2020 Table Leading Players of Graft Versus Host Disease (GVHD) Treatment by Type in 2020 Figure Example of Hospital Pharmacies Figure Global Graft Versus Host Disease (GVHD) Treatment for Hospital Pharmacies Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Retail Pharmacies Figure Global Graft Versus Host Disease (GVHD) Treatment for Retail Pharmacies Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Online Pharmacies Figure Global Graft Versus Host Disease (GVHD) Treatment for Online Pharmacies Revenue (Million $) and Growth Rate (2015-2020) Table Global Graft Versus Host Disease (GVHD) Treatment Sales by Application (2015-2020) Table Global Graft Versus Host Disease (GVHD) Treatment Sales Market Share by Application (2015-2020) Figure Global Graft Versus Host Disease (GVHD) Treatment Sales Market Share by Application in 2020 Table Leading Consumers of Graft Versus Host Disease (GVHD) Treatment by Application in 2020 Figure Example of Direct Channel Figure Global Graft Versus Host Disease (GVHD) Treatment for Direct Channel Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Distribution Channel Figure Global Graft Versus Host Disease (GVHD) Treatment for Distribution Channel Revenue (Million $) and Growth Rate (2015-2020) Table Global Graft Versus Host Disease (GVHD) Treatment Revenue by Sales Channel (2015-2020) Table Global Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Sales Channel (2015-2020) Figure Global Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Sales Channel in 2020 Table Leading Distributors/Dealers of Graft Versus Host Disease (GVHD) Treatment by Sales Channel in 2020 Table Global Graft Versus Host Disease (GVHD) Treatment Market Size and CAGR by Region (2015-2030) Table Global Graft Versus Host Disease (GVHD) Treatment Sales by Region (2015-2020) Table Global Graft Versus Host Disease (GVHD) Treatment Sales Market Share by Region (2015-2020) Figure Global Graft Versus Host Disease (GVHD) Treatment Sales Market Share by Region in 2020 Table Global Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) by Region (2015-2020) Table Global Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Region (2015-2020) Figure Global Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Region in 2020 Table North America Graft Versus Host Disease (GVHD) Treatment Sales by Country (2015-2020) Figure North America Graft Versus Host Disease (GVHD) Treatment Sales Market Share by Country (2015-2020) Table North America Graft Versus Host Disease (GVHD) Treatment Revenue by Country (2015-2020) Figure North America Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Country (2015-2020) Figure North America Graft Versus Host Disease (GVHD) Treatment Market Share by Type in 2020 Figure North America Graft Versus Host Disease (GVHD) Treatment Market Share by Application in 2020 Figure United States Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure United States Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure Canada Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Canada Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure Mexico Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Mexico Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Table Europe Graft Versus Host Disease (GVHD) Treatment Sales by Country (2015-2020) Figure Europe Graft Versus Host Disease (GVHD) Treatment Sales Market Share by Country (2015-2020) Table Europe Graft Versus Host Disease (GVHD) Treatment Revenue by Country (2015-2020) Figure Europe Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Country (2015-2020) Figure Europe Graft Versus Host Disease (GVHD) Treatment Market Share by Type in 2020 Figure Europe Graft Versus Host Disease (GVHD) Treatment Market Share by Application in 2020 Figure Germany Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Germany Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure UK Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure UK Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure France Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure France Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure Italy Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Italy Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure Russia Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Russia Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure Spain Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Spain Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Table Asia-Pacific Graft Versus Host Disease (GVHD) Treatment Sales by Country (2015-2020) Figure Asia-Pacific Graft Versus Host Disease (GVHD) Treatment Sales Market Share by Country (2015-2020) Table Asia-Pacific Graft Versus Host Disease (GVHD) Treatment Revenue by Country (2015-2020) Figure Asia-Pacific Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Country (2015-2020) Figure Asia-Pacific Graft Versus Host Disease (GVHD) Treatment Market Share by Type in 2020 Figure Asia-Pacific Graft Versus Host Disease (GVHD) Treatment Market Share by Application in 2020 Figure China Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure China Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure Japan Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Japan Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure Korea Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Korea Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure India Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure India Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure Southeast Asia Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Southeast Asia Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure Australia Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Australia Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Table South America Graft Versus Host Disease (GVHD) Treatment Sales by Country (2015-2020) Figure South America Graft Versus Host Disease (GVHD) Treatment Sales Market Share by Country (2015-2020) Table South America Graft Versus Host Disease (GVHD) Treatment Revenue by Country (2015-2020) Figure South America Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Country (2015-2020) Figure South America Graft Versus Host Disease (GVHD) Treatment Market Share by Type in 2020 Figure South America Graft Versus Host Disease (GVHD) Treatment Market Share by Application in 2020 Figure Brazil Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Brazil Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure Argentina Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Argentina Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure Colombia Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Colombia Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Table Middle East & Africa Graft Versus Host Disease (GVHD) Treatment Sales by Country (2015-2020) Figure Middle East & Africa Graft Versus Host Disease (GVHD) Treatment Sales Market Share by Country (2015-2020) Table Middle East & Africa Graft Versus Host Disease (GVHD) Treatment Revenue by Country (2015-2020) Figure Middle East & Africa Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Country (2015-2020) Figure Middle East & Africa Graft Versus Host Disease (GVHD) Treatment Market Share by Type in 2020 Figure Middle East & Africa Graft Versus Host Disease (GVHD) Treatment Market Share by Application in 2020 Figure UAE Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure UAE Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure Saudi Arabia Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure Saudi Arabia Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Figure South Africa Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate (2015-2020) Figure South Africa Graft Versus Host Disease (GVHD) Treatment Revenue (Million $) and Growth Rate (2015-2020) Table Company Snapshot of Abbott Table Graft Versus Host Disease (GVHD) Treatment Introduction of Abbott Table Graft Versus Host Disease (GVHD) Treatment Sales, Price, Revenue, Gross Margin and Market Share of Abbott (2018-2020) Table Industrial Chain of Graft Versus Host Disease (GVHD) Treatment Table Manufacturing Cost Structure of Graft Versus Host Disease (GVHD) Treatment Table General Manufacturing Process of Graft Versus Host Disease (GVHD) Treatment Table Leading Distributors/Dealers of Graft Versus Host Disease (GVHD) Treatment Table Leading Consumers of Graft Versus Host Disease (GVHD) Treatment Figure Global Graft Versus Host Disease (GVHD) Treatment Sales and Growth Rate Forecast (2021-2030) Figure Global Graft Versus Host Disease (GVHD) Treatment Revenue and Growth Rate Forecast (2021-2030) Table Global Graft Versus Host Disease (GVHD) Treatment Market Size and CAGR Forecast by Region (2021-2030) Table Global Graft Versus Host Disease (GVHD) Treatment Market Size and CAGR Forecast by Type (2021-2030) Table Global Graft Versus Host Disease (GVHD) Treatment Market Size and CAGR Forecast by Application (2021-2030) Table Global Graft Versus Host Disease (GVHD) Treatment Market Size and CAGR Forecast by Sales Channel (2021-2030)

Abbott AbbVie Allergan Anterogen Astellas Pharma Athersys Bristol-Myers Squibb Caladrius Eli Lilly GlaxoSmithKline Glenmark Kadmon Holdings Merck Mesoblast Neovii Biotech Novartis Osiris Therapeutics Pfizer Roche Sanofi Soligenix Takeda Pharmaceutical